Flower One Holdings Inc.
Flower One Holdings Inc.
Your view on FLOOF
Overview
What the company does, where it operates, and who runs it.
About Flower One Holdings Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Kellen O'Keefe
- Headquarters
- The Guinness Tower, Vancouver, BC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Kellen O'Keefe
- Headquarters
- The Guinness Tower, Vancouver, BC, CA
Flower One Holdings Inc. engages in the cultivation and production of medical and recreational cannabis. It owns and operates 400,000 square foot greenhouse for cannabis cultivation and 55,000 square foot cannabis production facility in Nevada; and 25,000 square-feet indoor cultivation and a commercial kitchen in Las Vegas.
The company cultivates, processes, produces, packages, and wholesales dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, beverages, topicals, and infused products. It provides cannabis products under the NLVO brand name.
The company sells its products directly to dispensaries, as well as engages in the contract cultivation, production, and packaging for consumer cannabis brands. Flower One Holdings Inc. is based in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Flower One Holdings Inc., and the rating behind it. FLOOF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Flower One Holdings Inc.. Starting points for Flower One Holdings Inc.: EPS -$0.12, beta 1.81 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Flower One Holdings Inc.. Flower One Holdings Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Flower One Holdings Inc.. Trailing twelve-month EPS for Flower One Holdings Inc. stands at -$0.12. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Flower One Holdings Inc.. Flower One Holdings Inc. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Flower One Holdings Inc. valued side by side against its closest peers. Flower One Holdings Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Flower One Holdings Inc., and how their positions are changing. At a $4,731 market value, institutional positions materially move Flower One Holdings Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Flower One Holdings Inc. executives and directors. Shares of Flower One Holdings Inc. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Flower One Holdings Inc.. Flower One Holdings Inc. is a $4,731 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Flower One Holdings Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Flower One Holdings Inc.. Coverage tracks Flower One Holdings Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.